ALDURAZYME® (laronidase) is indicated for the treatment of adult and pediatric patients with Hurler and Hurler-Scheie forms of Mucopolysaccharidosis I (MPS I) and for patients with the Scheie form who have moderate to severe symptoms.
Limitations of Use:
- The safety and effectiveness of treating mildly affected patients with the Scheie form have not been established.
- The effect of ALDURAZYME on central nervous system manifestations of the disorder has not been determined.
Explore Aldurazyme efficacy
LEARN MOREExplore Aldurazyme safety
SEE MORECoverage options for Aldurazyme
LEARN ABOUT COVERAGE6-MWT = six-minute walk test; FVC = forced vital capacity; MPS I = mucopolysaccharidosis type I.
Reference: 1. ALDURAZYME [prescribing information]. Cambridge, MA: Genzyme Corporation.